Skip to main content

Mar Tintore Subirana

I am a Neurologist and Head of Care at the Centre d'Esclerosi Multiple de Catalunya (Cemcat) of the Neurology/Neuroimmunology service of the Vall d'Hebron University Hospital. Since June 2023 I have been Head of Section at the Centre d'Esclerosi Multiple de Catalunya (Cemcat) of the Neurology/Neuroimmunology service of the Vall d'Hebron University Hospital. Since 2021 I have been a professor of Neurology at the University of Vic-Central University of Catalonia (UVic-UCC) and since October 2022 I have been Chair of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS).

Institutions of which they are part

Main researcher
Clinical Neuroimmunology
Vall Hebron Institut de Recerca
Clinical neuroimmunology
General Hospital
Responsable Assistencial
Multiple Sclerosis Centre of Catalonia

Mar Tintore Subirana

Institutions of which they are part

Main researcher
Clinical Neuroimmunology
Vall Hebron Institut de Recerca
Clinical neuroimmunology
General Hospital
Responsable Assistencial
Multiple Sclerosis Centre of Catalonia

I am a Neurologist and Head of Care at the Centre d'Esclerosi Multiple de Catalunya (Cemcat) of the Neurology/Neuroimmunology service of the Vall d'Hebron University Hospital. Since June 2023 I have been Head of Section at the Centre d'Esclerosi Multiple de Catalunya (Cemcat) of the Neurology/Neuroimmunology service of the Vall d'Hebron University Hospital. Since 2021 I have been a professor of Neurology at the University of Vic-Central University of Catalonia (UVic-UCC) and since October 2022 I have been Chair of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS).

I have developed in particular the study of prognostic factors, multiple sclerosis of the child and adolescent, as well as family planning in women with multiple sclerosis. I am currently a member of the Advisory Ethics Committee (CEA) of the Vall d'Hebron University Hospital.

I have published more than 260 articles in national and international journals and am a regular reviewer of indexed journals both national and international. My factor H is currently 60 and until May 2023 my work has received 15,464 citations.

Projects

Validación de marcadores biológicos asociados con la conversión a esclerosis múltiple en pacientes que presentan síndromes clínicos aislados

IP: Manuel Comabella Lopez
Collaborators: Mar Tintore Subirana
Funding agency: Instituto de Salud Carlos III
Funding: 134915
Reference: PI09/00788
Duration: 01/01/2010 - 30/06/2013

Estudio de marcadores biológicos pronóstico en pacientes con síndromes clínicos aislados sugestivos de esclorosis múltiple

IP: Mar Tintore Subirana
Collaborators: Jordi Rio Izquierdo, Rosalia Horno Ocaña, Alex Rovira Cañellas, Joaquin Castillo Justribo, Mireia Castillo Juarez, Georgina Arrambide García
Funding agency: Instituto de Salud Carlos III
Funding: 59229.5
Reference: PI080788
Duration: 01/01/2009 - 30/06/2012

Unitat de Neuroimmunologia Clínica (UNiC)

IP: Xavier Montalban Gairín
Collaborators: Susana Otero Romero, Carlos Nos Llopis, Sunny Malhotra Sareen, Jaume Sastre Garriga, Jordi Rio Izquierdo, Ingrid Galán Cartaña, Rosalia Horno Ocaña, Manuel Comabella Lopez, Silvia Soler García, Carmen Tur Gomez, Jordi Barquinero Mañez, Herena Eixarch Ahufinger, Montserrat Moreno Sánchez, Mar Tintore Subirana, M Jesus Arevalo Navines, Carmen Espejo Ruiz, Angela Vidal Jordana, Joaquin Castillo Justribo, Mireia Castillo Juarez, Nicolás Miguel Fissolo, Georgina Arrambide García
Funding agency: Agència Gestió Ajuts Universitaris i de Recerca
Funding: 43680
Reference: 2009 SGR 793
Duration: 01/01/2010 - 30/04/2014

Ensayo clínico, multicéntrico, con asignación aleatoria y doble ciego, para comparar la eficacia clinica y radiológica de dosis equivalentes de metilprednisolona administradas por vía oral o vía intravenosa en pacientes en brote de esclerosis múltiple.

IP: Mar Tintore Subirana
Collaborators: -
Funding agency: Instituto de Salud Carlos III
Funding:
Reference: CORTEM2007-000888-15
Duration: 01/01/2007 - 31/12/2008

Related news

In total, different projects of six research groups will be promoted, focusing on precision medicine and advanced therapies.

Dr. Carmen Espejo and Dr. Georgina Arrambide, researchers at Cemcat and Vall d'Hebron Research Institute, are the first authors of the article.

The research findings propose to modify the McDonald 2017 criteria, only in those in whom diagnosis using the current criteria is not possible.

Related professionals

Montse Rodriguez Gomez

Montse Rodriguez Gomez

Shock, Organ Dysfunction and Resuscitation
Read more
Miguel Angel Martinez Lopez

Miguel Angel Martinez Lopez

Predoctoral researcher
Microbiology
Read more
Maria del Carmen Sanchez  Valcarcel

Maria del Carmen Sanchez Valcarcel

Research assistant
Clinical Biochemistry, Drug Delivery & Therapy (CB-DDT)
Read more
Berta Roig Villar

Berta Roig Villar

Research technician
Psychiatry, Mental Health and Addictions
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.